Cancer patients are particularly vulnerable to hypoalbuminemia, a condition precipitated by various factors such as the increased release of proinflammatory cytokines and growth factors, which suppress albumin synthesis, alongside increased vascular permeability and deteriorated nutritional status. This evidence concerns the gene ALB and Hypoalbuminemia.